Trial Profile
A Pilot Phase 2a Blinded, Placebo Controlled, Multicenter Parallel Group, Dose Ranging Study to Evaluate the Safety and Preliminary Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloids
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 May 2014
Price :
$35
*
At a glance
- Drugs AZX 100 (Primary)
- Indications Keloids
- Focus Therapeutic Use
- Sponsors Capstone Therapeutics
- 20 May 2014 New trial record